Stay updated on Atezolizumab and Epacadostat Combination Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.

Latest updates to the Atezolizumab and Epacadostat Combination Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a new revision of the study record. This change updates the version history and related metadata without altering the reported study details.SummaryDifference0.1%

- Check21 days agoChange DetectedNo additions or deletions are listed for this page. Therefore, there are no textual changes to describe beyond the existing study record.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.5.3 appears on the page, replacing the prior v3.5.2. This seems to reflect a minor platform update rather than a modification to the study data or eligibility criteria.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page’s study record content and identifiers are updated, including a new last update posted date and refreshed formatting/values for study listing details. Older text about the study timeline and dose-description entries is replaced by the newer revision (e.g., showing updated last update timestamps and a more complete list of epacadostat dosing cohorts).SummaryDifference6%

- Check71 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page shows revision v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab and Epacadostat Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab and Epacadostat Combination Clinical Trial page.